The genetic engineering of organ-donor animals to decrease the risk of human immune system rejection poses ethical and psychological challenges to the long-held boundary between humans and other animal species.
An ethical case explores a lawsuit against Fred Hutchinson Cancer Center of Seattle by patients who claimed they were not told of the full risks associated with a clinical trial they participated in.